Literature DB >> 29155282

Seizure liability assessments using the hippocampal tissue slice: Comparison of non-clinical species.

Michael V Accardi1, Hai Huang1, Simon Authier2.   

Abstract

INTRODUCTION: Traditionally, rat hippocampal tissue slice models are used as an in vitro electrophysiology assay to assess seizurogenic potential in early drug development despite non-clinical species-specific differences noted during in vivo seizure studies.
METHODS: Hippocampal tissue slices were acutely isolated from rats, minipigs, dogs and nonhuman primates (NHP). Population spikes (PS) were evoked through stimulation of the CA3 Schaffer collateral pathway and recorded using in vitro electrophysiological techniques via an extracellular electrode placed within the CA1 stratum pyramidale cell body layer.
RESULTS: Hippocampal slices, across all species, displayed a concentration-dependent increase in PS area and number with the pro-convulsant pentylenetetrazol (PTZ; 0.1-10mM). Beagle dogs exhibited higher sensitivities to PTZ-induced changes in PS area and number compared to both rats and NHPs which presented nuanced differences in their responsiveness to PTZ modulation. Minipigs were comparatively resistant to PTZ-induced changes in both PS area and number. Rat and NHP hippocampal tissues were further characterized with the pro-convulsant agents 4-aminopyradine (4-AP; 1-100μM) and cefazolin (0.001-10mM). Rats possessed higher sensitivities to 4-AP- and cefazolin-induced changes to both PS area and number whereas NHP displayed greater modulation in PS duration. The anti-convulsant agents, diazepam (10-500μM) and lidocaine (1-500μM), were also tested on either rat and/or NHP tissue with both drugs repressing PS activation at high concentrations. DISCUSSION: Hippocampal tissue slices, across all species, possessed distinct sensitivities to pro- and anti-convulsant agents which may benefit the design of non-clinical seizure liability studies and their associated data interpretation.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Extracellular recording; Hippocampal tissue slice; In vitro electrophysiology; Preclinical animal species; Safety pharmacology; Seizure liability

Mesh:

Substances:

Year:  2017        PMID: 29155282     DOI: 10.1016/j.vascn.2017.11.003

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  4 in total

Review 1.  In vitro Models for Seizure-Liability Testing Using Induced Pluripotent Stem Cells.

Authors:  Alastair I Grainger; Marianne C King; David A Nagel; H Rheinallt Parri; Michael D Coleman; Eric J Hill
Journal:  Front Neurosci       Date:  2018-08-31       Impact factor: 4.677

2.  Functional Electron Microscopy, "Flash and Freeze," of Identified Cortical Synapses in Acute Brain Slices.

Authors:  Carolina Borges-Merjane; Olena Kim; Peter Jonas
Journal:  Neuron       Date:  2020-01-09       Impact factor: 17.173

3.  The opioid antagonist naltrexone decreases seizure-like activity in genetic and chemically induced epilepsy models.

Authors:  Morgan L Sturgeon; Rachel Langton; Shaunik Sharma; Robert A Cornell; Joseph Glykys; Alexander G Bassuk
Journal:  Epilepsia Open       Date:  2021-06-09

4.  Applicability of hiPSC-Derived Neuronal Cocultures and Rodent Primary Cortical Cultures for In Vitro Seizure Liability Assessment.

Authors:  Anke M Tukker; Fiona M J Wijnolts; Aart de Groot; Remco H S Westerink
Journal:  Toxicol Sci       Date:  2020-11-01       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.